Savient Pharmaceuticals (Nasdaq: SVNT) is trading down over 35% this morning after it received a letter from the FDA saying ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE